Tenaya Therapeutics Inc (TNYA) concluded trading on Thursday at a closing price of $2.75, with 7.57 million shares of worth about $20.83 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -26.47% during that period and on December 12, 2024 the price saw a loss of about -24.86%. Currently the company’s common shares owned by public are about 79.22M shares, out of which, 65.64M shares are available for trading.
Stock saw a price change of -17.17% in past 5 days and over the past one month there was a price change of 24.43%. Year-to-date (YTD), TNYA shares are showing a performance of -15.12% which increased to 36.14% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.61 but also hit the highest price of $7.01 during that period. The average intraday trading volume for Tenaya Therapeutics Inc shares is 3.00 million. The stock is currently trading -7.28% below its 20-day simple moving average (SMA20), while that difference is up 15.32% for SMA50 and it goes to -19.01% lower than SMA200.
Tenaya Therapeutics Inc (NASDAQ: TNYA) currently have 79.22M outstanding shares and institutions hold larger chunk of about 57.30% of that.
The stock has a current market capitalization of $217.86M and its 3Y-monthly beta is at 2.73. It has posted earnings per share of -$1.48 in the same period. It has Quick Ratio of 5.27 while making debt-to-equity ratio of 0.13. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TNYA, volatility over the week remained 14.95% while standing at 14.14% over the month.
Stock’s fiscal year EPS is expected to rise by 19.57% while it is estimated to increase by 7.86% in next year.
Coverage by Leerink Partners stated Tenaya Therapeutics Inc (TNYA) stock as an Outperform in their note to investors on November 30, 2023, suggesting a price target of $7 for the stock.
